Dorothy Pettay
Emory University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Dorothy Pettay.
American Journal of Human Genetics | 1999
Dana C. Crawford; Kellen L. Meadows; James L. Newman; Lisa Taft; Dorothy Pettay; Laura B. Gold; S. Jane Hersey; Elizabeth F. Hinkle; Mary L. Stanfield; Patricia Holmgreen; Marshalyn Yeargin-Allsopp; Coleen A. Boyle; Stephanie L. Sherman
We conducted a large population-based survey of fragile X (FRAXA) syndrome in ethnically diverse metropolitan Atlanta. The eligible study population consisted of public school children, aged 7-10 years, in special education-needs (SEN) classes. The purpose of the study was to estimate the prevalence among whites and, for the first time, African Americans, among a non-clinically referred population. At present, 5 males with FRAXA syndrome (4 whites and 1 African American), among 1,979 tested males, and no females, among 872 tested females, were identified. All males with FRAXA syndrome were mentally retarded and had been diagnosed previously. The prevalence for FRAXA syndrome was estimated to be 1/3,460 (confidence interval [CI] 1/7,143-1/1,742) for the general white male population and 1/4, 048 (CI 1/16,260-1/1,244) for the general African American male population. We also compared the frequency of intermediate and premutation FRAXA alleles (41-199 repeats) and fragile XE syndrome alleles (31-199 repeats) in the SEN population with that in a control population, to determine if there was a possible phenotype consequence of such high-repeat alleles, as has been reported previously. No difference was observed between our case and control populations, and no difference was observed between populations when the probands were grouped by a rough estimate of IQ based on class placement. These results suggest that there is no phenotype consequence of larger alleles that would cause carriers to be placed in an SEN class.
Genetics in Medicine | 1999
Quanhe Yang; Stephanie L. Sherman; Terry Hassold; Katherine Allran; Lisa Taft; Dorothy Pettay; Muin J. Khoury; J. David Erickson; Sallie B. Freeman
Purpose: We examined maternal smoking and oral contraceptive use as possible risk factors in the genesis of cases of trisomy 21 of maternal origin. This is the first epidemiological study to categorize cases of trisomy 21 by parent of origin and timing of the meiotic error before assessing possible risk factors.Methods: We used chromosome 21-specific DNA markers to assign origin to each case. Structured interviews were employed to deter-mine maternal smoking and oral contraceptive use around conception.Results: The odds ratio (OR) for maternal smoking was significantly increased among younger mothers (OR = 2.98; 95% CI = 1.01–8.87), but only in a particular subset of meiotically-derived cases. The combined use of cigarettes and oral contraceptives increased the risk further (OR = 7.62; 95% CI = 1.63–35.6); however, oral contraceptive use alone was not a significant risk factor.Conclusion: Our results indicate that categorizing cases of trisomy 21 by parent and timing of the meiotic error allows more precision in identifying risk factors and may shed light on mechanisms of meiotic nondisjunction.
Human Genetics | 1992
Terry Hassold; Dorothy Pettay; Arthur Robinson; Irene A. Uchida
SummaryThe present report summarizes molecular studies of parental origin and sex chromosome mosaicism in forty-one 45,X conceptuses, consisting of 29 spontaneous abortions and 12 liveborn individuals with Turner syndrome. Our studies indicate that most 45,X conceptuses have a single, maternally derived X chromosome, regardless of whether the conceptus is liveborn or spontaneously aborted. In studies of mosaicism, our identification of X- and Y-chromosome mosaics among 45,X spontaneous abortions indicates that mosaicism does not ensure survival to term of 45,X fetuses. However, the incidence of sex chromosmome mosaicism is substantially higher in liveborn than in aborted 45,X conceptuses, indicating that the presence of a second cell line increases the likelihood of survival to term.
American Journal of Medical Genetics | 1996
Kellen L. Meadows; Dorothy Pettay; James L. Newman; Jane Hersey; Allison E. Ashley; Stephanie L. Sherman
To begin to understand the population dynamics of the fragile X (FRAXA) mutation and to learn more about the fragile X E (FRAXE) syndrome, we have initiated a surve of children in special needs education programs in the public school system. With respect to the FRAXA syndrome, we found approximately 1/1,000 full mutations among males. No large alleles at the FRAXE locus were observed among 462 individuals. The allele distributions at the two loci among Caucasians and among African Americans were examined as well as the level of heterozygosity. We found a significant difference in the FRAXA allele distribution among the two ethnic groups; the major difference was due to the lack of smaller alleles among the African Americans. No difference was found for the FRAXE allele distribution among the two groups. The level of heterozygosity was less than predicted by the allele distribution at both loci. This is probably due to unidentified large alleles among females with a test result of a single band. Alternatively, this excess may indicate that the population is not at equilibrium.
Human Genetics | 1990
Terry Hassold; Dorothy Pettay; Kristin M. May; Arthur Robinson
SummaryX-linked DNA markers were used to determine the parental origin of the additional sex chromosomes in eight individuals with sex chromosome tetrasomy or pentasomy. In all cases studied, one parent contributed a single sex chromosome while the other parent contributed three or four sex chromosomes. Thus, it seems likely that most, if not all, sex chromosome tetrasomy and pentasomy is attributable to successive nondisjunctional events involving the same parent.
European Journal of Human Genetics | 1998
Rowena S. James; Katrina H. Ellis; Dorothy Pettay; Patricia A. Jacobs
We studied four families each with three trisomy 21 conceptions. In two of the families the trisomy 21 conceptions all occurred when the mothers were under 35 years of age and in the other two families they all occurred when the mothers were over 35 years of age. Cytogenetic studies showed low level mosaic trisomy 21 in the two younger mothers, but not in the two older. In the three families tested using molecular techniques the results were consistent with the additional chromosome 21 in the trisomic conceptuses being maternally derived. Novel alleles were detected in the trisomic offspring of one of the younger mothers, demonstrating that the mother had been conceived as a trisomy with three different chromosomes 21. Therefore the multiple trisomy 21 pregnancies in the two younger mothers resulted from maternal trisomy 21 mosaicism, but may have been due to chance in the older mothers.
American Journal of Medical Genetics | 1996
Sallie B. Freeman; Kasinathan Muralidharan; Dorothy Pettay; R. Dwain Blackston; Kristin M. May
We present a 6-year-old girl with a balanced 11;20 translocation [46,XX,t(11;20)(q13.1;q13.13)pat], asplenia, pulmonic stenosis, Hirschsprung disease, minor anomalies, and mental retardation. This case represents the second report of an individual with situs abnormalities and a balanced chromosome rearrangement involving a breakpoint at 11q13. Polymerase chain reaction (PCR) analysis of microsatellite markers excluded uniparental disomy for chromosomes 11 and 20. Segregation analysis of markers in the 11q13 region in the proposita and her phenotypically normal carrier sibs did not show a unique combination of maternal and paternal alleles in the patient. We discuss several possible explanations for the simultaneous occurrence of situs abnormalities and a balanced 11;20 translocation. These include (1) chance, (2) a further chromosome rearrangement in the patient, (3) gene disruption and random situs determination, and (4) gene disruption plus transmission of a recessive or imprinted allele from the mother.
Nature Genetics | 1996
Neil E. Lamb; Sallie B. Freeman; Amanda Savage-Austin; Dorothy Pettay; Lisa Taft; Jane Hersey; Yuanchao Gu; Joe Shen; Denise Saker; Kristen M. May; Dimitris Avramopoulos; Michael B. Petersen; Anni Hallberg; Margareta Mikkelsen; Terry Hassold; Stephanie L. Sherman
Human Molecular Genetics | 1997
Neil E. Lamb; Eleanor Feingold; Amanda Savage; Dimitris Avramopoulos; Sallie B. Freeman; Yuanchao Gu; Anni Hallberg; Jane Hersey; Georgia Karadima; Dorothy Pettay; Denise Saker; Joe Shen; Lisa Taft; Margareta Mikkelsen; Michael B. Petersen; Terry Hassold; Stephanie L. Sherman
Human Molecular Genetics | 1994
Stephanie L. Sherman; Michael B. Petersen; Sallie B. Freeman; Jane Hersey; Dorothy Pettay; Lisa Taft; Merete Frantzen; Margareta Mikkelsen; Terry Hassold